InvestorsHub Logo
Followers 20
Posts 1059
Boards Moderated 0
Alias Born 04/01/2013

Re: Chabojilo post# 16556

Saturday, 10/12/2013 11:20:59 AM

Saturday, October 12, 2013 11:20:59 AM

Post# of 426690
I think most people have a weekend to review the docs and read the story, the damage of the headline is done, it won't be undone but it won't add to the pain anymore. Anyone that sold on the idea the FDA had decided REDUCE IT was needed for approval are likely not buying back until after Adcomm anyways now that they are out.

Anyone know of someone blogging the meeting that would be unbiased(AF excluded obviously)? I Will be at work and not able to listen to most of it. I suspect the nitty gritty will come from the FDA presentation in the afternoon and the subsequent discussions all day to get a feel for the view of the panel.

I'm tempted to ignore it all and then refresh the press release page on AMRN's website at the end of the day and see what the vote was but I sit at a computer most of the day and can't imagine I will be able to do that. AF will have a negative bent on everything said of course. The message boards and such might get convoluted with bears...hoping SR blogs, though he is long biased he will just give the facts with less inflammatory commenting than AF.

On the positive side re:AF he is hedging his view of a negative vote due to safety not being a concern. Even though he believes the Committee will vote no and believes they will conclude REDUCE IT is needed he still hedges with they may approve anyways due to safety profile. So even the most negative person believes approval is not a big reach.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News